Clinical Characteristics and Surgical Outcomes of Complications of Proliferative Diabetic Retinopathy in Young versus Older Patients with Type 2 Diabetes

References

• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Zhang G, Chen H, Chen W, Zhang M. Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study. Br J Ophthalmol. 2017;101(12):1591–1595. doi:10.1136/bjophthalmol-2017-310316
   PubMed Web of Science ®Google Scholar
• Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–1786. doi:10.1001/jama.2014.3201
   PubMed Web of Science ®Google Scholar
• McMahon SK, Haynes A, Ratnam N, et al. Increase in type 2 diabetes in children and adolescents in Western Australia. Med J Aust. 2004;180(9):459–461. doi:10.5694/j.1326-5377.2004.tb06023.x
   PubMed Web of Science ®Google Scholar
• Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146(5):693–700. doi:10.1016/j.jpeds.2004.12.042
   PubMed Web of Science ®Google Scholar
• Zou W, Ni L, Lu Q, et al. Diabetes onset at 31–45 years of age is associated with an increased risk of diabetic retinopathy in type 2 diabetes. Sci Rep. 2016;6:38113. doi:10.1038/srep38113
   PubMed Web of Science ®Google Scholar
• Singerman LJ, Weaver DT. PDR in juvenile onset diabetics: high-risk proliferative diabetic retinopathy in juvenile onset diabetics. Retina. 1981;1(1):18–26.
   PubMedGoogle Scholar
• Wong J, Molyneaux L, Constantino M, Twigg SM, Yue DK. Timing is everything: age of onset influences long-term retinopathy risk in type 2 diabetes, independent of traditional risk factors. Diabetes Care. 2008;31(10):1985–1990. doi:10.2337/dc08-0580
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Liu HY, Hernandez-Da Mota SE, et al. Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta- analysis of randomized controlled trials. Am J Ophthalmol. 2013;156(1):106–15.e2. doi:10.1016/j.ajo.2013.02.008
   PubMed Web of Science ®Google Scholar
• Zhao XY, Xia S, Chen YX. Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials. Br J Ophthalmol. 2018;102(8):1077–1085. doi:10.1136/bjophthalmol-2017-311344
   PubMed Web of Science ®Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909
   PubMed Web of Science ®Google Scholar
• Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore malay eye study. Ophthalmology. 2008;115(11):1869–1875. doi:10.1016/j.ophtha.2008.05.014
   PubMed Web of Science ®Google Scholar
• Forga L, Goñi MJ, Ibáñez B, Cambra K, García-Mouriz M, Iriarte A. Influence of age at diagnosis and time-dependent risk factors on the development of diabetic retinopathy in patients with type 1 diabetes. J Diabetes Res. 2016;2016:9898309. doi:10.1155/2016/9898309
   PubMed Web of Science ®Google Scholar
• Kokkonen J, Laatikainen L, van Dickhoff K, et al. Ocular complications in young adults with insulin-dependent diabetes mellitus since childhood. Acta Paediatr. 1994;83(3):273–278. doi:10.1111/j.1651-2227.1994.tb18093.x
   PubMed Web of Science ®Google Scholar
• LeCaire TJ, Palta M, Klein R, Klein BE, Cruickshanks KJ. Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from the Wisconsin diabetes registry study and the Wisconsin epidemiologic study of diabetic retinopathy. Diabetes Care. 2013;36(3):631–637. doi:10.2337/dc12-0863
   PubMed Web of Science ®Google Scholar
• Wu YB, Wang CG, Chen C, Xu LX, Su GF, Zhou XB. Analysis of risk factors for progressive fibrovascular proliferation in proliferative diabetic retinopathy. Int Ophthalmol. 2020;40(10):2495‑2502. doi:10.1007/s10792-020-01428-y
   Web of Science ®Google Scholar
• Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Identification of independent risk factors for the development of diabetic retinopathy requiring treatment. Acta Ophthalmol. 2011;89(6):515–521. doi:10.1111/j.1755-3768.2009.01742.x
   PubMed Web of Science ®Google Scholar
• Kostraba JN, Klein R, Dorman JS, et al. The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol. 1991;133(4):381–391. doi:10.1093/oxfordjournals.aje.a115892
   PubMed Web of Science ®Google Scholar
• Mengyu L, Xiaohong W, Jinguo Y, et al. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients. BMC Ophthalmol. 2020;20(1):416. doi:10.1186/s12886-020-01688-3
   PubMed Web of Science ®Google Scholar
• Lovestam-Adrian M, Agardh CD, Torffvit O, Agardh E. Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care. J Diabetes Complications. 2001;15(6):287–294. doi:10.1016/S1056-8727(01)00167-2
   PubMed Web of Science ®Google Scholar
• Shah CP, Ho AC, Regillo CD, et al. Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment. Retina. 2008;28(5):723–728. doi:10.1097/IAE.0b013e318166976d
   PubMed Web of Science ®Google Scholar
• Cyrus MS, Charu G, Daraius S, Neelam A, Priyanka G, Dutta R. Ranjan Dimanual microincision vitreous surgery for severe proliferative diabetic retinopathy outcome in more than 300 eyes. Retina. 2018;38(Suppl 1):S134–S145. doi:10.1097/IAE.0000000000002093
   PubMedGoogle Scholar
• Huang CH, Hsieh YT, Yang CM, et al. Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes. Graefes Arch Clin Exp Ophthalmol. 2017;255(5):863–871. doi:10.1007/s00417-016-3579-4
   PubMed Web of Science ®Google Scholar
• Raczyńska D, Zorena K, Urban B, et al. Current trends in the monitoring and treatment of diabetic retinopathy in young adults. Mediators Inflamm. 2014;2014:492926. doi:10.1155/2014/492926
   PubMed Web of Science ®Google Scholar